Resources
BNET Resources
- sort by:
- Relevance
- Date
- Popularity
- Rhodia Strategically Positions Its Pharma Ingredients Business.(Brief Article)(Statistical Data Included)
- Rhodia is repositioning its pharmaceutical ingredients business as part of its strategy to expand its leading position in key markets. A major part of that strategy is to reinforce its status as a high-security, low-risk global supplier of pharmace Rhodia is repositioning its pharmaceutical...
- Research articles 2000-04-03
- Rhodia Targets GMP Manufacturing.
- RHODIA IS PLANNING a fivefold increase in its sales of pharmaceutical intermediates made to current Good Manufacturing Practice GMP standards during the next five years. Last year, the company acquired its first cGMP plant, a facility in Ho ...
- Research articles 1999-08-09
- Bulk analgesics moving to handful of big players.
- BASF buyout of Celanese in BHC is latest consolidation move. THE US BULK analgesics market is consolidating, and there could be more moves to come. BASF Corporation's acquisition of 100 percent control of ibuprofen venture BHC last month was t ...
- Research articles 1998-01-12
- European specialty players revamp and replace their strategy. (Focus 2003: Specialty Chemicals/ChemSpec Europe Preview).
- Threatened with commoditization, companies take drastic measures, not only cutting costs and divesting operations, but also seeking an entirely different, closer relationship with their customers. Under pressure from sluggish demand, difficult Threatened with commoditization, companies take drastic measures, ...
- Research articles 2003-04-28
- Bulk Analgesics Moving To Handful of Big Players
- BASF buyout of Celanese in BHC is latest consolidation move. THE US BULK analgesics market is consolidating, and there could be more moves to come. BASF Corporation's acquisition of 100 percent control of ibuprofen venture BHC last month was the l BASF buyout...
- Research articles 1998-01-12
- Rhodia Acquires GMP Unit in UK From RPR.(Rhone-Poulenc Rorer )(Brief Article)
- RHODIA IS EXPANDING its contract manufacturing activities in pharmaceutical intermediates by acquiring its first multipurpose plant that has received Food and Drug Administration approval for current Good Manufacturing Practice cGMP. The co RHODIA IS EXPANDING its contract manufacturing...
- Research articles 1998-12-21
- Chirality a Hot Commodity For Fine Chemical Players.(chiral molecules, single enantiomer drugs)
- Rhodia Chirex, Dow and Cambrex beef up the toolbox. SEVERAL CONTRACT manufacturing companies are stepping up their ability to serve a potentially lucrative market area: the development, manufacture and supply of novel chiral molecules. Compani Rhodia Chirex, Dow and...
- Research articles 2000-12-18
- Rhodia to Invest in Contract Manufacturing.
- RHODIA PLANS to invest [epsilon]30 million ($30 million) this year in facilities for pharmaceutical contract manufacturing to help it meet its target of a four-fold increase in custom synthesis sales, to [epsilon]120 million, by 2004. The inv RHODIA...
- Research articles 2000-03-27
- Rhodia's Deal For ChiRex Draws Skepticism.(Brief Article)
- Analysts caution that obstacles may be greater than the companies expect. RHODIA'S BID to take over ChiRex, the US-based pharmaceutical contract research and manufacturing company, underscores the specialty chemicals manufacturer's determinat Analysts caution that obstacles may be greater...
- Research articles 2000-07-31
Additional Resources
- Rhodia is raising the prices of its bulk active pharmaceutical ingredients. (Pharmaceuticals in Brief).(Brief Article)
- RHODlA is raising the prices of its bulk active pharmaceutical ingredients, including acetylsalicylic acid aspirin, salicylic acid, methyl salicylate and paracetamol (acetaminophen, or APAP) products, by 5 percent ... RHODlA is raising the prices of its bulk active pharmaceutical ingredients, including acetylsalicylic acid...
- Research articles 2003-04-14
- Business news in brief
- IN THE REGION Chemicals firm opens research center in Bristol Rhodia Inc., a specialty-chemicals company, opened its North American research and technical center in Bristol, Bucks County, the company said in a statement yesterday. It moved its operations from Cranbury, N.J. The new Bristol facility houses laboratories that...
- Research articles 2006-06-27
- << Previous
- page 1 of 1
- Next >>




